P2Y12 platelet receptor drugs for Atherosclerotic Cardiovascular Disease

2 tracked P2Y12 platelet receptor drugs in the Atherosclerotic Cardiovascular Disease race. The class explanation lives on the P2Y12 platelet receptor page; the full indication pipeline across every mechanism is on the Atherosclerotic Cardiovascular Disease page.

1 Phase 31 Phase 1

Head-to-head evidence: Evategrel (CG-0255) vs Sumecigrel

The roster

← all P2Y12 platelet receptor drugs